Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching ...
Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness
Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...
Accenture CEO Julie Sweet diagnosed with cancer, to undergo surgery next week
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...
Accenture CEO Julie Sweet diagnosed with early-stage breast cancer, treatment likely to last 12-16 weeks
Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.
AOL5d
Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...
Accenture CEO diagnosed with breast cancer, to undergo surgery next week
However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the ...
Accenture rolls back DEI goals to comply with Trump’s EOs
CEO Julie Sweet said the company would end its employee diversity representation goals and put “a greater focus on inclusion ...
These founders and investors want the longevity industry to cater to women—whatever their budget
Data from the National Center for Health Statistics shows that women in the United States currently live an average of 5.8 ...
Investing6d
Accenture CEO Julie Sweet shares health update
Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.